feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Chicago mom loses sight, skin from common drug

Chicago mom loses sight, skin from common drug

16 Jan

•

Summary

  • Woman lost nearly 90% of skin and sight due to drug reaction.
  • Lamotrigine triggered Stevens-Johnson Syndrome, a rare side effect.
  • She underwent multiple surgeries, including for blindness and scarring.
Chicago mom loses sight, skin from common drug

A Chicago woman, Emily McAllister, experienced a life-altering reaction to lamotrigine, a widely used medication for epilepsy and bipolar disorder. This rare side effect, known as Stevens-Johnson Syndrome (SJS), led to the loss of approximately 87 percent of her skin and permanent blindness in both eyes.

McAllister's symptoms began in September 2022, shortly after starting lamotrigine. The condition rapidly progressed, causing widespread blistering and skin detachment, necessitating a seven-week stay in a burn unit. Over the past three years, she has endured extensive medical procedures, including multiple eye surgeries and tissue transplants.

SJS, a potentially fatal condition, affects an estimated 1 to 2 people per million annually in the United States. The FDA mandates a Black Box Warning for lamotrigine due to the risk of SJS and Toxic Epidermal Necrolysis (TEN), urging careful monitoring of patients. McAllister continues to face medical challenges but remains determined to regain her sight.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
SJS is a rare, severe skin reaction to medications that causes widespread blistering and peeling. Emily McAllister lost nearly 90% of her skin and her sight due to SJS triggered by lamotrigine.
Yes, lamotrigine can trigger SJS, which can damage the eyes, leading to severe inflammation, scarring, and permanent vision loss, as experienced by Emily McAllister.
The debilitating reaction Emily McAllister suffered is extremely rare, estimated at 1 in 2,500, and SJS itself affects about 1 to 2 people per million annually in the U.S.

Read more news on

Healthside-arrow
trending

Mortgage rates hit 3-year low

trending

Spotify Premium price increase

trending

Teddi Mellencamp's cancer battle

trending

Verizon offers outage credit

trending

Indiana winter storm warning

trending

Barcelona edges Racing Santander 2-0

trending

Vitaly Zdorovetskiy to be deported

trending

Sophie Turner plays Lara Croft

trending

Bruins retire Zdeno Chara's

You may also like

Doctor's 'Eureka!' Moment Saves Patient's Life

11 Jan • 29 reads

Cancer at 29: My Life With Colorectal Diagnosis

11 Jan • 18 reads

article image

Woman Hospitalized by Sun: A Rare 'Vampire' Allergy

20 Dec, 2025 • 115 reads

article image

McLeod's Daughters Star Rachael Carpani Dies at 45

16 Dec, 2025 • 145 reads

article image

Adrian Chiles: Cancer, ADD, and Liver Woes Revealed

4 Dec, 2025 • 205 reads

article image